Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein
The spike protein receptor-binding domain (RBD) of SARS-CoV-2 is the molecular target for many vaccines and antibody-based prophylactics aimed at bringing COVID-19 under control. Such a narrow molecular focus raises the specter of viral immune evasion as a potential failure mode for these biomedical...
Main Authors: | Van Egeren, Debra, Novokhodko, Alexander, Stoddard, Madison, Tran, Uyen, Zetter, Bruce, Rogers, Michael, Pentelute, Bradley L., Carlson, Jonathan M., Hixon, Mark, Joseph-McCarthy, Diane, Chakravarty, Arijit |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Chemistry |
Format: | Article |
Published: |
Public Library of Science (PLoS)
2021
|
Online Access: | https://hdl.handle.net/1721.1/130548 |
Similar Items
-
Controlling long-term SARS-CoV-2 infections can slow viral evolution and reduce the risk of treatment failure
by: Debra Van Egeren, et al.
Published: (2021-11-01) -
Rapid relaxation of pandemic restrictions after vaccine rollout favors growth of SARS-CoV-2 variants: A model-based analysis.
by: Debra Van Egeren, et al.
Published: (2021-01-01) -
Vaccines Alone Cannot Slow the Evolution of SARS-CoV-2
by: Debra Van Egeren, et al.
Published: (2023-04-01) -
Computational identification of antibody-binding epitopes from mimotope datasets
by: Rang Li, et al.
Published: (2024-02-01) -
Antibody escape, the risk of serotype formation, and rapid immune waning: Modeling the implications of SARS-CoV-2 immune evasion.
by: Catherine Albright, et al.
Published: (2023-01-01)